Home > Coronavirus/COVID-19 > E-LEGAL® ARTICLE – COVID-19 – PANDEMIC MARKETING AUTHORISATION FOR MEDICINAL PRODUCTS

E-LEGAL® ARTICLE – COVID-19 – PANDEMIC MARKETING AUTHORISATION FOR MEDICINAL PRODUCTS

Summary
The focus of this article will be on the analysis of the administrative rules associated with the marketing authorisation of medicinal products, based on the European scenario.
The aim is to find out whether or not the current regime can meet the new needs brought by the Covid-19 pandemic, since so far there is neither a vaccine nor a specific antiviral medication to prevent or treat it, despite the race to discover the drug or vaccine to “cure” it, to which substantial efforts and investment have been devoted to. Read more…